• Lactobacillus gasseri Modulates Colitis via NR1I3–E-cadherin

  2026-06-08

  The referenced study demonstrates that Lactobacillus gasseri ATCC33323 significantly ameliorates DSS-induced colitis in mice through the NR1I3-mediated regulation of E-cadherin. This mechanistic insight advances our understanding of probiotic interventions in intestinal barrier function and offers a refined target for future IBD therapies.

• Deferasirox: Mechanistic Insights and Ferroptosis Modulation

  2026-06-08

  Explore how Deferasirox, an advanced oral iron chelator, modulates ferroptosis and iron metabolism in cancer research. This article delivers a mechanistic deep-dive, uniquely connecting cutting-edge molecular findings to practical assay decisions.

• Lactate-GPR81/FARP1 Axis Enables Insulin-Independent Glucose

  2026-06-07

  This study identifies a lactate-driven, GPR81/FARP1-mediated signaling pathway that drives glucose uptake in skeletal muscle independently of insulin. The findings offer mechanistic insight into exercise-induced glycemic control and highlight new avenues for metabolic disease intervention by targeting GPCR signaling.

• S Tag Peptide (A6007): Protocols for Protein Solubility & De

  2026-06-06

  S Tag Peptide addresses protein solubility and detection challenges in recombinant protein workflows by providing a compact, highly soluble fusion tag compatible with robust antibody-based assays. It is most effective for protein engineering, affinity purification, and detection applications where minimal structural interference is critical. Its use is not recommended for workflows requiring enzymatic activity from the S-peptide itself, as the peptide is inactive alone.

• Topotecan HCl: Optimizing Topoisomerase 1 Inhibitor Workflow

  2026-06-05

  Harness the precision of Topotecan HCl for reproducible, quantitative cancer research. This guide translates cutting-edge evidence into actionable protocols, troubleshooting insights, and strategic advantages for lung carcinoma and prostate cancer models.

• EZ Cap™ Human PTEN mRNA: Next-Gen Immunomodulation in Cancer

  2026-06-05

  Explore how EZ Cap™ Human PTEN mRNA enables advanced tumor suppressor gene mRNA delivery for immunomodulation and precision cancer research. This article reveals unique translational and protocol insights not covered in prior resources.

• Applied Workflows with the DiscoveryProbe FDA-approved Drug

  2026-06-04

  Harness clinically validated compounds for high-throughput antiviral, oncology, and neurodegenerative screening with the DiscoveryProbe FDA-approved Drug Library. This guide details experimental workflows, troubleshooting, and real-world applications, translating benchmark studies into actionable strategies for translational research.

• Azithromycin in Senolytic Drug Discovery: Beyond Antibacteri

  2026-06-04

  Explore the advanced role of Azithromycin as a macrolide antibiotic in senolytic drug discovery, bridging bacterial infection research and cellular aging. This article provides unique scientific insights and practical assay guidance for innovative researchers.

• NADPH Oxidase-ROS Drive Arterial Contraction via L-Type Ca2+

  2026-06-03

  A recent study in early postnatal rats demonstrates that NADPH oxidase-derived reactive oxygen species (ROS) promote arterial contraction predominantly through activation of L-type voltage-gated Ca2+ channels, rather than through classical kinase pathways. These findings clarify the molecular mechanisms of vascular tone regulation in developmental physiology and provide a refined framework for kinase inhibitor control studies.

• Hepatic sEH Drives Osteoclastogenesis via Nrf2 Suppression i

  2026-06-03

  This study uncovers a novel liver-bone axis in osteoporosis, demonstrating that hepatic soluble epoxide hydrolase (sEH) promotes osteoclast differentiation by suppressing the Nrf2 signaling pathway. The findings establish a mechanistic link between sEH-driven lipid metabolism, redox imbalance, and bone loss, opening new avenues for targeted intervention in metabolic bone disease.

• KN-62: Mechanistic Precision for Translational Calcium Signa

  2026-06-02

  Explore how KN-62, a potent and selective CaMKII inhibitor, transforms translational research by enabling targeted manipulation of calcium-dependent signaling pathways. This article delivers mechanistic insight, evaluates experimental benchmarks, and provides actionable guidance for leveraging KN-62 in metabolism, secretion, and cell cycle studies—escalating the discussion beyond conventional product pages.

• Lipoamino Bundle LNPs Enable Spleen-Targeted mRNA Delivery

  2026-06-02

  This study introduces a novel class of lipoamino bundle lipid nanoparticles (LNPs) engineered for efficient mRNA transfection of dendritic cells and macrophages with remarkable spleen selectivity. The findings provide new strategies for targeted mRNA delivery, with implications for vaccine and immunotherapy development.

• ATRX Deficiency Sensitizes Glioma to Selective PDGFRα/β Inhi

  2026-06-01

  This study uncovers that high-grade glioma cells lacking ATRX are significantly more sensitive to receptor tyrosine kinase and PDGFR inhibition than their ATRX-proficient counterparts. These findings highlight the importance of ATRX status for interpreting inhibitor responses and optimizing targeted therapy strategies in glioblastoma and related cancers.

• Bedaquiline: Diarylquinoline Antibiotic for Tuberculosis and

  2026-06-01

  Bedaquiline is a diarylquinoline antibiotic that inhibits Mycobacterium tuberculosis F1FO-ATP synthase, targeting both subunit c and ε. This mechanism yields bactericidal action against multi-drug resistant tuberculosis, with additional effects on cancer cell metabolism. Its verified pharmacokinetic and biochemical properties make it a cornerstone for translational research in infectious disease and oncology.

• HyperTrap Heparin HP: Advancing Stemness and Signaling Resea

  2026-05-31

  Explore how the HyperTrap Heparin HP Column empowers translational researchers to interrogate cancer stem cell signaling and protein purification challenges, with strategic insights into protocol design, competitive advantages, and the evolving landscape of affinity chromatography in cancer biology.

16382 records 1/1093 page Next 12345 下5页 Last page